Autophagy-mediated anti-tumoral activity of imiquimod in Caco-2 cells

Biochemical and Biophysical Research Communications

Volumn 386, Issue 3, 2009, Pages 455-458

  Yi, Jae Youn ^b   Jung, Yu Jin ^c   Choi, Sun Shim ^c   Hwang, Jungjin ^d   Chung, Eunkyung ^a  

^a Hallym University   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c Kangwon National University   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

Author keywords

Anti tumoral activity; Apoptosis; Autophagy; Caco 2 cells; Imiquimod; TLR7; TNF alpha

Indexed keywords

IMIQUIMOD; LOXORIBINE; RAPAMYCIN; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CELL DEATH; CELL ORGANELLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG POTENCY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CACO-2 CELLS; HUMANS; LIGANDS; TOLL-LIKE RECEPTOR 7;

EID: 67650064587     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.046     Document Type: Article

References (26)

1. Garland S.M. Imiquimod. Curr. Opin. Infect. Dis. 16 (2003) 85-89
2. Schon M.P., and Schon M. TLR7 and TLR8 as targets in cancer therapy. Oncogene 27 (2008) 190-199
3. Schon M., and Schon M.P. The antitumoral mode of action of imiquimod and other imidazoquinolines. Curr. Med. Chem. 14 (2007) 681-687
4. Schon M.P., and Schon M. Imiquimod: mode of action. Br. J. Dermatol. 157 Suppl. 2 (2007) 8-13
5. Schwartz M.J., Liu H., Hwang D.H., Kawamoto H., and Scherr D.S. Antitumor effects of an imidazoquinoline in renal cell carcinoma. Urology 73 (2009) 1156-1162
6. Smith E.B., Schwartz M., Kawamoto H., You X., Hwang D., Liu H., and Scherr D.S. Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder. J. Urol. 177 (2007) 2347-2351
7. Lee J.R., Shin J.H., Park J.H., Song S.U., and Choi G.S. Combined treatment with intratumoral injection of dendritic cells and topical application of imiquimod for murine melanoma. Clin. Exp. Dermatol. 32 (2007) 541-549
8. Vidal D., Matias-Guiu X., and Alomar A. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis. Br. J. Dermatol. 151 (2004) 656-662
9. Sullivan T.P., Dearaujo T., Vincek V., and Berman B. Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping. Dermatol. Surg. 29 (2003) 1181-1186
10. Meyer T., Nindl I., Schmook T., Ulrich C., Sterry W., and Stockfleth E. Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures. Br. J. Dermatol. 149 Suppl. 66 (2003) 9-14
11. Schon M.P., Wienrich B.G., Drewniok C., Bong A.B., Eberle J., Geilen C.C., Gollnick H., and Schon M. Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. J. Invest. Dermatol. 122 (2004) 1266-1276
12. Schon M., Bong A.B., Drewniok C., Herz J., Geilen C.C., Reifenberger J., Benninghoff B., Slade H.B., Gollnick H., and Schon M.P. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J. Natl. Cancer Inst. 95 (2003) 1138-1149
13. Delgado M.A., Elmaoued R.A., Davis A.S., Kyei G., and Deretic V. Toll-like receptors control autophagy. EMBO J. 27 (2008) 1110-1121
14. Iwasaki A. Role of autophagy in innate viral recognition. Autophagy 3 (2007) 354-356
15. Lee H.K., Lund J.M., Ramanathan B., Mizushima N., and Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315 (2007) 1398-1401
16. Levine B., and Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 6 (2004) 463-477
17. Mizushima N., Ohsumi Y., and Yoshimori T. Autophagosome formation in mammalian cells. Cell. Struct. Funct. 27 (2002) 421-429
18. Lum J.J., DeBerardinis R.J., and Thompson C.B. Autophagy in metazoans: cell survival in the land of plenty. Nat. Rev. Mol. Cell Biol. 6 (2005) 439-448
19. Kourtis N., and Tavernarakis N. Autophagy and cell death in model organisms. Cell Death Differ. 16 (2009) 21-30
20. Jin S., and White E. Role of autophagy in cancer: management of metabolic stress. Autophagy 3 (2007) 28-31
21. Moretti L., Yang E.S., Kim K.W., and Lu B. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resist. Updat. 10 (2007) 135-143
22. Hoyer-Hansen M., and Jaattela M. Autophagy: an emerging target for cancer therapy. Autophagy 4 (2008) 574-580
23. Levine B. Cell biology: autophagy and cancer. Nature 446 (2007) 745-747
24. N. Chen, V. Karantza-Wadsworth, Role and regulation of autophagy in cancer, Biochim. Biophys. Acta (2009), article in press.
25. Cheng Y., Qiu F., Tashiro S., Onodera S., and Ikejima T. ERK and JNK mediate TNFalpha-induced p53 activation in apoptotic and autophagic L929 cell death. Biochem. Biophys. Res. Commun. 376 (2008) 483-488
26. Sivaprasad U., and Basu A. Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-alpha-induced cell death in MCF-7 cells. J. Cell. Mol. Med. 12 (2008) 1265-1271